The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients
![HealthCast:A Look Into COVID-19's Impact on Cancer Patients](https://govciomedia.com/wp-content/uploads/2023/12/1000x650_Cancer_HealthCast_Dr_Larissa_Korde_v1.jpeg?fit=max&auto=format&cs=adobergb1998&auto=compress)
An NCI study examines the crossroads between cancer and COVID-19 diagnoses.
![HealthCast:A Look Into COVID-19's Impact on Cancer Patients](https://govciomedia.com/wp-content/uploads/2023/12/1000x650_Cancer_HealthCast_Dr_Larissa_Korde_v1.jpeg?fit=max&auto=format&cs=adobergb1998&auto=compress)
-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
Inside VA’s Lighthouse for App Development
Andrew Fichter discusses how Lighthouse is serving veterans and why it is necessary for modernization of veterans services.
24m listen -
Exploring the Link Between Climate Change and Public Health
Dr. John Balbus, Climate Change and Health Equity Director, HHS
35m listen -
Transparency Around Cyber Attacks Can Prevent Future Ones
Cybersecurity leader Suzanne Spaulding said implementing radical transparency in cybersecurity can benefit federal agencies and national security overall.
21m listen -
Emerging Tech Parallels Emerging Risks for VA Health Care
Amber Pearson, Executive Director, Information Security Policy and Strategy, VA
20m listen